Altamimi Saleh, Khalil Adli, Khalaiwi Khalid A, Milner Ruth A, Pusic Martin V, Al Othman Mohammed A
Department of Emergency Medicine and Pediatrics, King Fahad Medical City, Riyadh, Saudi Arabia.
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD004872. doi: 10.1002/14651858.CD004872.pub3.
The standard duration of treatment for children with acute group A beta hemolytic streptococcus (GABHS) pharyngitis with oral penicillin is 10 days. Shorter duration antibiotics may have comparable efficacy.
To summarize the evidence regarding the efficacy of two to six days of newer oral antibiotics (short duration) compared to 10 days of oral penicillin (standard duration) in treating children with acute GABHS pharyngitis.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2012, Issue 3) which contains the Cochrane Acute Respiratory Infections Group's Specialized Register, MEDLINE (January 1966 to March week 3, 2012) and EMBASE (January 1990 to April 2012).
Randomized controlled trials (RCTs) comparing short duration oral antibiotics to standard duration oral penicillin in children aged 1 to 18 years with acute GABHS pharyngitis.
Two review authors scanned the titles and abstracts of retrieved citations and applied the inclusion criteria. We retrieved included studies in full, and extracted data. Two review authors independently assessed trial quality.
We included 20 studies with 13,102 cases of acute GABHS pharyngitis. The updated search did not identify any new eligible studies; the majority of studies were at high risk of bias. However, the majority of the results were consistent. Compared to standard duration treatment, the short duration treatment studies had shorter periods of fever (mean difference (MD) -0.30 days, 95% confidence interval (CI) -0.45 to -0.14) and throat soreness (MD -0.50 days, 95% CI -0.78 to -0.22); lower risk of early clinical treatment failure (odds ratio (OR) 0.80, 95% CI 0.67 to 0.94); no significant difference in early bacteriological treatment failure (OR 1.08, 95% CI 0.97 to 1.20) or late clinical recurrence (OR 0.95, 95% CI 0.83 to 1.08). However, the overall risk of late bacteriological recurrence was worse in the short duration treatment studies (OR 1.31, 95% CI 1.16 to 1.48), although no significant differences were found when studies of low dose azithromycin (10 mg/kg) were eliminated (OR 1.06, 95% CI 0.92 to 1.22). Three studies reported long duration complications. Out of 8135 cases of acute GABHS pharyngitis, only six cases in the short duration treatment versus eight in the standard duration treatment developed long-term complications in the form of glomerulonephritis and acute rheumatic fever, with no statistically significant difference (OR 0.53, 95% CI 0.17 to 1.64).
AUTHORS' CONCLUSIONS: Three to six days of oral antibiotics had comparable efficacy compared to the standard duration 10-day course of oral penicillin in treating children with acute GABHS pharyngitis. . In areas where the prevalence of rheumatic heart disease is still high, our results must be interpreted with caution.
A组β溶血性链球菌(GABHS)所致急性咽炎儿童口服青霉素的标准治疗疗程为10天。较短疗程的抗生素可能具有相似的疗效。
总结与口服青霉素10天(标准疗程)相比,新型口服抗生素治疗2至6天(短疗程)对急性GABHS咽炎患儿疗效的证据。
我们检索了Cochrane对照试验中心注册库(CENTRAL 2012年第3期),其中包含Cochrane急性呼吸道感染小组的专业注册库、MEDLINE(1966年1月至2012年3月第3周)和EMBASE(1990年1月至2012年4月)。
比较1至18岁急性GABHS咽炎患儿短疗程口服抗生素与标准疗程口服青霉素的随机对照试验(RCT)。
两位综述作者浏览检索到的文献的标题和摘要,并应用纳入标准。我们获取了纳入研究的全文,并提取了数据。两位综述作者独立评估试验质量。
我们纳入了20项研究,共13102例急性GABHS咽炎病例。更新后的检索未发现任何新的符合条件的研究;大多数研究存在偏倚风险较高的问题。然而,大多数结果是一致的。与标准疗程治疗相比,短疗程治疗研究的发热时间(平均差(MD)-0.30天,95%置信区间(CI)-0.45至-0.14)和咽痛时间(MD -0.50天,95%CI -0.78至-0.22)较短;早期临床治疗失败风险较低(比值比(OR)0.80,95%CI 0.67至0.94);早期细菌学治疗失败(OR 1.08,95%CI 0.97至1.20)或晚期临床复发(OR 0.95,95%CI 0.83至1.08)无显著差异。然而,短疗程治疗研究中晚期细菌学复发的总体风险更差(OR 1.31,95%CI 1.16至1.48),尽管排除低剂量阿奇霉素(10mg/kg)的研究后未发现显著差异(OR 1.06,95%CI 0.92至1.22)。三项研究报告了长期并发症。在8135例急性GABHS咽炎病例中,短疗程治疗组仅有6例发生肾小球肾炎和急性风湿热形式的长期并发症,标准疗程治疗组有8例,无统计学显著差异(OR 0.53,95%CI 0.17至1.64)。
在治疗急性GABHS咽炎患儿方面,口服抗生素3至6天与标准疗程10天的口服青霉素疗效相当。在风湿性心脏病患病率仍然较高的地区,对我们的结果必须谨慎解读。